Smoking Long or Ultralong Cigarettes Increases Risk of Lung Cancer

(Chicago, Illinois – October 28, 2013)—Smokers of long or ultralong cigarettes are at greater risk for lung and oral cancer than smokers of regular and king-size cigarettes, according to researchers at the Harvard School of Public Health, Center for Global Tobacco Control.

“We found that of smokers of long or ultralong cigarettes have higher concentrations of tobacco specific carcinogens in their urine than smokers of regular or king size cigarettes,” said Constantine Vardavas, MD, senior research scientist, Harvard School of Public Health.

Vardavas and colleagues compared urine tests among 3,699 smokers of regular, king-sized and long or ultralong cigarettes using data from the National Health and Nutrition Examination Surveys (NHANES) from 2007-2010. Smokers of king-sized cigarettes accounted for 53% of total smokers, smokers of long or ultralong cigarettes constituted 31.5%, and smokers of regular-sized cigarettes made up the remaining 15.4% of the smoker population. They found that smokers of long or ultralong cigarettes had significantly higher levels of NNAL—an indicator of tobacco-specific carcinogen—in their urine. In addition, researchers found that older smokers, non-Hispanic blacks, and females had a greater tendency to smoke long or ultralong cigarettes.

“While the significant risks of smoking are well known and accepted, very little information exists on the health risks of different sizes of cigarettes,” said Darcy Marciniuk, MD, FCCP and President of the ACCP. “This study indicates that there is an added risk to those smoking long and ultralong cigarettes.”

CHEST 2013 is the 79th annual meeting of the American College of Chest Physicians, held October 26-31 in Chicago, Illinois. The ACCP is the global leader in clinical chest medicine, representing 18,700 members who provide patient care in the areas of pulmonary, critical care, and sleep medicine in the United States and throughout the world. The mission of the ACCP is to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. For information about the ACCP, visit the ACCP website at www.chestnet.org, or follow the ACCP on Facebook and Twitter and the meeting hashtag, #CHEST2013.

 

ACCP Contact

Linda Stepanich
lstepanich@yahoo.com
(847) 682-3251

 

Back to Press Releases